Clinical Trial Update: FFA-Induced Hypertension and Endothelial Dysfunction [NA]

View source ↗

Summary

Clinical trial update on fatty acid amide (FFA)-induced hypertension and endothelial dysfunction; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Hypertension

Snippet

Sponsor: Emory University | Conditions: Endothelial Dysfunction, Hypertension | NA | Status: COMPLETED | Results posted: 2014-07-09